ANDREW S. T. PORTER D.O., FAAFP
Prescription History 1962458828
Family Medicine - Sports Medicine in Wichita, KS


Quality Rating: 77.32 out of 100 score

NPI Status: Active since May 25, 2006

Contact Information

707 N EMPORIA ST
WICHITA, KS
ZIP 67214
Phone: (316) 858-3460
Fax: (316) 858-3458

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ANDREW S. T. PORTER D.O., FAAFP, an active Sports Medicine specialist practicing in Wichita, KS. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 92 documented patient claims. Among these therapy options, the most frequently utilized medication is Meloxicam, which accounts for 30 claims alone.

Medication Index


Atorvastatin Calcium

Generic Formulation: Atorvastatin CalciumSpecialty: Sports Medicine
Provider Metrics Summary
Total Claims 13
30-Day Fills 39.0
Days Supply 1,170
KS State Average Benchmarks
Peer Average Claims189.0
Peer Average 30-Day Fills440.2
Peer Average Days Supply13,059
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 93.1% less volume than the regional standard for practitioners inside KS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $64.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.96

State Avg Cost Per Claim

$11.12

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

Therapeutic Applications

Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Donepezil Hcl

Generic Formulation: Donepezil HclSpecialty: Sports Medicine
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 360
KS State Average Benchmarks
Peer Average Claims56.0
Peer Average 30-Day Fills83.4
Peer Average Days Supply2,366
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 78.6% less volume than the regional standard for practitioners inside KS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $54.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.50

State Avg Cost Per Claim

$14.20

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain.

Fluoxetine Hcl

Generic Formulation: Fluoxetine HclSpecialty: Sports Medicine
Provider Metrics Summary
Total Claims 11
30-Day Fills 25.0
Days Supply 750
KS State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills68.9
Peer Average Days Supply2,024
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 72.5% less volume than the regional standard for practitioners inside KS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $41.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.79

State Avg Cost Per Claim

$13.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.

Therapeutic Applications

This long-acting form of fluoxetine is used to treat depression in people who have been successfully treated with the form of fluoxetine that is taken daily. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI). SSRIs work by helping to restore the balance of certain natural substances in the brain (neurotransmitters such as serotonin). Fluoxetine may decrease anxiety, improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living.

Levothyroxine Sodium

Generic Formulation: Levothyroxine SodiumSpecialty: Sports Medicine
Provider Metrics Summary
Total Claims 15
30-Day Fills 39.0
Days Supply 1,170
KS State Average Benchmarks
Peer Average Claims169.0
Peer Average 30-Day Fills350.4
Peer Average Days Supply10,221
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 91.1% less volume than the regional standard for practitioners inside KS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $177.86 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.86

State Avg Cost Per Claim

$14.08

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Meloxicam

Generic Formulation: MeloxicamSpecialty: Sports Medicine
Provider Metrics Summary
Total Claims 30
30-Day Fills 52.0
Days Supply 1,560
KS State Average Benchmarks
Peer Average Claims60.0
Peer Average 30-Day Fills104.0
Peer Average Days Supply3,067
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside KS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $163.33 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.44

State Avg Cost Per Claim

$6.36

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Prednisone

Generic Formulation: PrednisoneSpecialty: Sports Medicine
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 80
KS State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills51.9
Peer Average Days Supply916
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 74.4% less volume than the regional standard for practitioners inside KS. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $21.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$1.99

State Avg Cost Per Claim

$5.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Therapeutic Applications

Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like ANDREW S. T. PORTER D.O., FAAFP provides transparency into local medical care patterns within Wichita, KS.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Sports Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.